70467_Journal Article.pdf (654 kB)
Epigenetic regulation of prostate cancer
journal contribution
posted on 2023-05-17, 06:28 authored by Chin, SP, Joanne DickinsonJoanne Dickinson, Adele HollowayAdele HollowayProstate cancer is a commonly diagnosed cancer in men and a leading cause of cancer deaths. Whilst the underlying mechanisms leading to prostate cancer are still to be determined, it is evident that both genetic and epigenetic changes contribute to the development and progression of this disease. Epigenetic changes involving DNA hypo- and hypermethylation, altered histone modifications and more recently changes in microRNA expression have been detected at a range of genes associated with prostate cancer. Furthermore, there is evidence that particular epigenetic changes are associated with different stages of the disease. Whilst early detection can lead to effective treatment, and androgen deprivation therapy has a high response rate, many tumours develop towards hormone-refractory prostate cancer, for which there is no successful treatment. Reliable markers for early detection and more effective treatment strategies are, therefore, needed. Consequently, there is a considerable interest in the potential of epigenetic changes as markers or targets for therapy in prostate cancer. Epigenetic modifiers that demethylate DNA and inhibit histone deacetylases have recently been explored to reactivate silenced gene expression in cancer. However, further understanding of the mechanisms and the effects of chromatin modulation in prostate cancer are required. In this review, we examine the current literature on epigenetic changes associated with prostate cancer and discuss the potential use of epigenetic modifiers for treatment of this disease.
History
Publication title
Clinical EpigeneticsPagination
151-169ISSN
1868-7075Department/School
Menzies Institute for Medical ResearchPublisher
SpringerPlace of publication
GermanyRights statement
The final publication is available at http://www.springerlink.comRepository Status
- Open